Physician profile
Ladislau Albert
NPI 1407149149
$2,061.41
in general payments reported to CMS, 2019-2025
10 companies · $360 in 2025
The $360 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $90.72 · 2021: $52.84 · 2022: $120 · 2023: $394 · 2024: $1,044 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,134 · Travel and Lodging: $664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,134.08 |
| Travel and Lodging | $663.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ctl Medical Corporation | $1,086.99 | 2023-2024 | Spinal |
| Si-Bone, INC. | $582.72 | 2020-2025 | |
| Stryker Corporation | $103.44 | 2022 | |
| Alafair Biosciences, INC. | $84.99 | 2024 | Versawrap |
| Kci USA, INC. | $52.84 | 2021 | |
| Innovation Technologies INC | $49.64 | 2025 | Irrisept |
| Baxter Healthcare | $49.18 | 2023 | Floseal |
| Providence Medical Technology, INC. | $25.71 | 2025 | |
| Abbott Laboratories | $16.80 | 2022 | |
| Ossur Americas, INC. | $9.10 | 2024 | Miami J |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ladislau Albert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.